Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 71
Filtrar
2.
J Am Board Fam Med ; 37(1): 150-152, 2024 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-38448234

RESUMO

In hospitalized patients with type 2 diabetes (T2DM), a less aggressive supplemental insulin regimen is noninferior to a standard, more aggressive, supplemental regimen.


Assuntos
Diabetes Mellitus Tipo 2 , Insulina , Humanos , Insulina/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Glicemia , Esquema de Medicação , Pacientes Internados , Hipoglicemiantes/uso terapêutico , Hospitalização
3.
J Fam Pract ; 72(7): E23-E25, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37729142

RESUMO

While treatment with metformin or lifestyle modification reduces risk for T2D in patients with prediabetes, neither intervention ultimately offers a mortality benefit.


Assuntos
Metformina , Estado Pré-Diabético , Humanos , Estado Pré-Diabético/diagnóstico , Estado Pré-Diabético/terapia , Terapia Comportamental , Estilo de Vida , Metformina/uso terapêutico
4.
J Fam Pract ; 72(7): 320-321, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37729143

RESUMO

YES. Low-dose naltrexone is as effective as amitriptyline in the treatment of painful diabetic neuropathy and has a superior safety profile (strength of recommendation [SOR], B; single randomized controlled trial [RCT]). Low-dose naltrexone significantly reduced pain by 32% in inflammatory conditions and 44% in neuropathic conditions (SOR, B; single retrospective cohort study). Doses as low as 5.4 mg were found to reduce pain in 95% of patients with fibromyalgia (SOR, B; single prospective dose-response study).


Assuntos
Fibromialgia , Naltrexona , Humanos , Naltrexona/uso terapêutico , Manejo da Dor , Amitriptilina , Fibromialgia/tratamento farmacológico , Dor
6.
J Fam Pract ; 72(4): E10-E11, 2023 05.
Artigo em Inglês | MEDLINE | ID: mdl-37224546

RESUMO

NO. Hormone replacement therapy (HRT) does not prevent cognitive decline in postmenopausal women-and in fact, it may slightly increase risk (strength of recommendation, A; systematic review, meta-analysis of randomized controlled trials [RCTs], and individual RCT).


Assuntos
Disfunção Cognitiva , Pós-Menopausa , Feminino , Humanos , Disfunção Cognitiva/prevenção & controle , Terapia de Reposição Hormonal , Ensaios Clínicos Controlados Aleatórios como Assunto
8.
J Fam Pract ; 72(1): E10-E12, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36749976

RESUMO

Yes, patients should do just that. In a randomized clinical trial, symptom duration was reduced when teens and young adults observed a certain screen-time hiatus.


Assuntos
Traumatismos em Atletas , Concussão Encefálica , Síndrome Pós-Concussão , Adulto Jovem , Adolescente , Humanos , Síndrome Pós-Concussão/diagnóstico , Traumatismos em Atletas/diagnóstico , Fatores de Tempo , Eletrônica
10.
Prim Care ; 49(4): 609-619, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36357065

RESUMO

During the COVID-19 pandemic, providers and patients explored the use of telehealth on a wide and rapid scale. Reflecting on how prenatal providers and pregnant patients used telehealth during the pandemic and afterward, we review existing and new lessons learned from the pandemic. This article summarizes international and national guidelines on prenatal care, presents practice examples on how telehealth and remote patient monitoring were used during the COVID-19 pandemic, and offers lessons learned and suggestions for future care.


Assuntos
COVID-19 , Telemedicina , Gravidez , Feminino , Humanos , Pandemias , Cuidado Pré-Natal , SARS-CoV-2
11.
J Fam Pract ; 71(6): E16-E17, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35994761

RESUMO

YES. Infants respond to behavioral interventions, although objective data are limited. Behavioral interventions include establishing regular daytime and sleep routines for the infant, reducing environmental noises or distractions, and allowing for self-soothing at bedtime (strength of recommendation: B, based on multiple randomized and nonrandomized studies).


Assuntos
Terapia Comportamental , Sono , Criança , Humanos , Lactente
19.
J Fam Pract ; 70(4): E5-E6, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-34339367

RESUMO

NO. Insulin glargine may lead to less patient-reported, symptomatic, and nocturnal hypoglycemia, although overall, there may not be a difference in the risk for severe hypoglycemia orhypoglycemiarelated emergency department (ED) visits and hospitalizations (strength of recommendation [SOR]: B, systematic review of randomized controlled trials [RCTs], individual RCTs, and observational study).


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemia/induzido quimicamente , Insulina Glargina/efeitos adversos , Insulina Glargina/uso terapêutico , Insulina Isófana/efeitos adversos , Insulina Isófana/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
20.
J Fam Pract ; 70(5): 244-246, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-34410915

RESUMO

This RCT provided valuable insights as to whether CRP-guided prescribing could safely reduce antibiotic use during acute COPD exacerbations.


Assuntos
Antibacterianos/farmacologia , Proteína C-Reativa/análise , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Antibacterianos/uso terapêutico , Humanos , Doença Pulmonar Obstrutiva Crônica/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA